Home - Softhale

Softhaler®

The Next Generation of Soft Mist Inhalators

Developing inhalative pharmaceutical products

Inhaler Platform Technology

Our Platform for Innovative Inhalation Products

Softhale

Experienced in the pharmaceutical industry

Find out more

01 / Extending Softhale

We are extending our in-house capabilities and competences to prepare the company...

Find out more

02 / ISO certified

Softhale successfully achieved certification of its’ quality management system for medical devices.

Find out more

03 / Our team of experts

Expertise in the pharmaceutical industry, our team is passionate about our work at Softhale.

We are developing the next generation of Soft Mist Inhalers

About us

Softhale is developing pharmaceutical inhalation products for major respiratory markets in the USA, Europe, and Asia. These products are based upon a differentiated inhalation delivery technology called SOFTHALER®. This device is a next-generation Soft Mist Inhaler (SMI) which offers a platform technology for delivering various drugs to the lungs. As well as generic products, innovative products are also targeted.

Our recent News

8 July 2021

Softhale certified to ISO 13485

30 March 2021

Sino Biopharmaceutical Ltd acquires Softhale

About us

Company

Based in Diepenbeek, Belgium, Softhale N.V. is a pharmaceutical company specializing in the development of inhalable respiratory products for the medical treatment of various indications.

Meet our Team of Experts

As a group, our Board offers profound medical, pharmaceutical/chemical, medical device, and consumer product expertise. It consists of members of the Series A & B multi-national venture capital consortium, the CEO, a non-executive director, a founder’s representative, and the chairman.

Meet our team

We're here for you

Please get in touch, it would be great to hear from you!

Contact